SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
380Piper: Myriad Genetics (MYGN - $13.73) Market Perform Volatility: Medimopgcw-8/19/2004
379<i>hard to know what to make of a company with this kind of clinical and pcharlyt-8/19/2004
378Myriad Genetics "market outperform," estimates raised Thursday, Augusscaram(o)uche-8/19/2004
377>> hard to know what to make of a company with this kind of clinical and pscaram(o)uche-8/19/2004
376Rick, 1. <I> (missed it)</I> - - post operative ileus 2. mentionedsoftware salesperson-8/19/2004
375Pretty good CC I thought. Had to check my old notes but that HIV drug was origicharlyt-8/18/2004
374Dan Christianson (sp.?) is on the call. R-flurbie results due "within sescaram(o)uche-8/18/2004
373Myriad Genetics Reports Financial Results for Fiscal 2004 Wednesday August 18, 6mopgcw-8/18/2004
372given that an approved substance P antagonist is out there (Merck), these observscaram(o)uche-8/7/2004
371Genes Dev. 2004 Jul 15;18(14):1737-52. Tal, a Tsg101-specific E3 ubiquitin liscaram(o)uche-8/4/2004
370nytimes.com By Accident, Utah Is Proving an Ideal Genetic Laboratory By KIRK JOscaram(o)uche-7/31/2004
369Neuroepidemiology. 2004 Jul-Aug;23(4):159-69. Nonsteroidal anti-inflammatory scaram(o)uche-7/29/2004
368businessweek.com By Amy Tsao Genetic Testing Meet Mad Ave. Myriad Geneticsscaram(o)uche-7/28/2004
367(Dr. Morham is first inventor listed on US 20030171318) appft1.uspto.govscaram(o)uche-7/24/2004
366J Biol Chem. 2004 Jun 23 [Epub ahead of print] The human endosomal complex reqscaram(o)uche-7/24/2004
365Peptides. 2004 Jul;25(7):1205-8. Role of substance P in hypersensitivity reacscaram(o)uche-7/24/2004
364Morning (but not for you)! Thanks! (eom)scaram(o)uche-7/21/2004
363First Albany: We are maintaining our Buy rating following presentation of data amopgcw-7/21/2004
362Piper: MYGN :Announces Positive Results of Phase I Trial at Alzheimer's 200mopgcw-7/21/2004
361Myriad Genetics Presents Phase I Results at International Conference on Alzheimescaram(o)uche-7/20/2004
360Muscle Nerve. 2004 Jul;30(1):95-101. Inactivity-induced modulation of Hsp20 ascaram(o)uche-7/10/2004
3591 Name of Reporting Person S.S. or I.R.S. Identification No. of Above Personscaram(o)uche-7/9/2004
358Thanks!! >> However, we look to get more constructive on the name in 1H:0scaram(o)uche-7/9/2004
357Piper Snip from a 1H review: We expect Myriad will release safety data on Flurimopgcw-7/9/2004
356Piper: Myriad Genetics (MYGN - $14.09) Market Perform Volatility: Mediummopgcw-7/9/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News